Nairo Quintana disqualified from 2022 Tour de France for tramadol use
Nairo Quintana has been stripped of his sixth overall finish at the 2022 Tour de France after tramadol was found in his system at the race.
Use of tramadol in-competition has been banned since March 2019 “in order to protect the riders’ health and safety in light of the side-effects of this substance” the UCI explained in a statement announcing they had sanctioned the 32-year-old.
Two dried blood samples provided by Quintana on July 8 and 13 during the Tour contained both tramadol and its two main metabolites.
This is an infringement of ‘UCI Medical Rules’, cycling’s governing body made clear in its statement, and does not constitute an Anti-Doping Rule Violation. As this is his first offence the Colombian is not suspended from racing and so can line-up for the Vuelta a España, which starts this week.
Quintana has 10 days to appeal the decision before the Court of Abitration, having also yesterday announced a three-year contract extension with his team Arkéa-Samsic.
The UCI collected a total of 120 dried blood samples as part of the tramadol programme during the 2022 Tour de France, with samples collected by the International Testing Agency (ITA).
More to follow…
Read More
0 Commentaires